1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. RADIOPHARMACEUTICALS MARKET, BY APPLICATION (USD BILLION)
6.1. Diagnosis
6.2. Therapy
6.3. Research
7. RADIOPHARMACEUTICALS MARKET, BY TYPE (USD BILLION)
7.1. Diagnostic Radiopharmaceuticals
7.2. Therapeutic Radiopharmaceuticals
8. RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS (USD BILLION)
8.1. Radioisotopes
8.2. Radiolabeled Compounds
8.3. Radiopharmaceutical Generators
9. RADIOPHARMACEUTICALS MARKET, BY END USE (USD BILLION)
9.1. Hospitals
9.2. Diagnostic Imaging Centers
9.3. Research Institutions
10. RADIOPHARMACEUTICALS MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Radiopharmaceuticals Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Radiopharmaceuticals Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Northstar Medical Radioisotopes
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Bracco Imaging
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Nordion
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Advanced Accelerator Applications
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. United Imaging Healthcare
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Lantheus
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. GE Healthcare
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Cleveland Clinic
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Novartis
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Telix Pharmaceuticals
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Bayer
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Elekta
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Cardinal Health
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Siemens Healthineers
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Itheon Pharmaceuticals
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 3. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 4. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 5. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 6. NORTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 7. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 8. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 9. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 10. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 11. US RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 12. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 13. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 14. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 15. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 16. CANADA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 17. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 18. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 19. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 20. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 21. EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 22. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 23. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 24. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 25. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 26. GERMANY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 27. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 28. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 29. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 30. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 31. UK RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 32. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 33. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 34. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 35. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 36. FRANCE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 37. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 38. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 39. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 40. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 41. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 42. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 43. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 44. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 45. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 46. ITALY RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 47. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 48. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 49. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 50. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 51. SPAIN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 52. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 53. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 54. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 55. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 56. REST OF EUROPE RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 57. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 58. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 59. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 60. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 61. APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 62. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 63. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 64. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 65. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 66. CHINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 67. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 68. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 69. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 70. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 71. INDIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 72. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 73. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 74. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 75. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 76. JAPAN RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 77. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 78. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 79. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 80. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 81. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 82. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 83. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 84. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 85. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 86. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 87. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 88. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 89. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 90. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 91. THAILAND RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 92. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 93. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 94. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 95. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 96. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 97. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 98. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 99. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 100. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 101. REST OF APAC RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 102. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 103. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 104. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 105. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 106. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 107. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 108. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 109. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 110. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 111. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 112. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 113. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 114. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 115. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 116. MEXICO RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 117. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 118. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 119. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 120. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 121. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 127. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 128. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 129. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 130. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 131. MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 132. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 133. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 134. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 135. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 136. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 137. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 138. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 139. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 140. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 141. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 142. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 143. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 144. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY RADIOPHARMACEUTICAL CLASS, 2019-2035 (USD BILLIONS)
TABLE 145. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 146. REST OF MEA RADIOPHARMACEUTICALS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 3. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 4. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 5. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 6. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 7. US RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 9. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 10. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 11. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 12. CANADA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 14. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 15. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 16. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 17. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 18. GERMANY RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 20. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 21. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 22. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 23. UK RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 25. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 26. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 27. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 28. FRANCE RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 30. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 31. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 32. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 33. RUSSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 35. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 36. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 37. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 38. ITALY RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 40. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 41. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 42. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 43. SPAIN RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 45. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 46. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 47. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 48. REST OF EUROPE RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC RADIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 50. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 51. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 52. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 53. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 54. CHINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 56. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 57. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 58. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 59. INDIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 61. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 62. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 63. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 64. JAPAN RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 66. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 67. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 68. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 69. SOUTH KOREA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 71. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 72. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 73. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 74. MALAYSIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 76. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 77. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 78. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 79. THAILAND RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 81. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 82. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 83. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 84. INDONESIA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 86. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 87. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 88. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 89. REST OF APAC RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 91. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 92. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 93. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 94. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 95. BRAZIL RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 97. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 98. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 99. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 100. MEXICO RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 102. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 103. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 104. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 105. ARGENTINA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 107. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 108. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 109. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 110. REST OF SOUTH AMERICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA RADIOPHARMACEUTICALS MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 113. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 114. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 115. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 116. GCC COUNTRIES RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 118. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 119. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 120. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 121. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
FIGURE 123. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY TYPE
FIGURE 124. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY RADIOPHARMACEUTICAL CLASS
FIGURE 125. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY END USE
FIGURE 126. REST OF MEA RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF RADIOPHARMACEUTICALS MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF RADIOPHARMACEUTICALS MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: RADIOPHARMACEUTICALS MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: RADIOPHARMACEUTICALS MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: RADIOPHARMACEUTICALS MARKET
FIGURE 133. RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2025 (% SHARE)
FIGURE 134. RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
FIGURE 135. RADIOPHARMACEUTICALS MARKET, BY TYPE, 2025 (% SHARE)
FIGURE 136. RADIOPHARMACEUTICALS MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
FIGURE 137. RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS, 2025 (% SHARE)
FIGURE 138. RADIOPHARMACEUTICALS MARKET, BY RADIOPHARMACEUTICAL CLASS, 2019 TO 2035 (USD Billions)
FIGURE 139. RADIOPHARMACEUTICALS MARKET, BY END USE, 2025 (% SHARE)
FIGURE 140. RADIOPHARMACEUTICALS MARKET, BY END USE, 2019 TO 2035 (USD Billions)
FIGURE 141. RADIOPHARMACEUTICALS MARKET, BY REGIONAL, 2025 (% SHARE)
FIGURE 142. RADIOPHARMACEUTICALS MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
